| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/11/2009 | EP2033999A1 Ozonized surfactant |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
| 03/11/2009 | EP2033687A1 Compositions comprising MAO inhibitors |
| 03/11/2009 | EP2033660A1 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 03/11/2009 | EP2033635A1 Short-chain fatty acid derivatives for treating pruritus |
| 03/11/2009 | EP2033628A2 Cosmetic use of a Bifidobacterium species lysate for treating dry skin |
| 03/11/2009 | EP2033627A2 Use of a Bifidobacterium species lysate for treating sensitive skin |
| 03/11/2009 | EP1641463B1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 03/11/2009 | EP1635776B9 Lipidic protein-transfer systems and cosmetic/dermatological use thereof |
| 03/11/2009 | EP1613294B1 Peptides and derivatives thereof as inhibitors of oxidative damage of the skin |
| 03/11/2009 | EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1435899B1 A composition for promoting hair growth |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1301460B9 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 03/11/2009 | EP1299081B9 Use of oligosaccharides to stimulate beta-endorphin production |
| 03/11/2009 | EP1221985B1 Conveyance of anti-infective activity to wound dressings |
| 03/11/2009 | EP1135094B1 Method to reduce hair loss and stimulate hair regrowth |
| 03/11/2009 | EP0988374B1 Hydrophilic composition containing protease produced by vibrio proteolyticus |
| 03/11/2009 | CN101384595A Salt of CD 80 antagonist |
| 03/11/2009 | CN101384246A External preparation for skin containing flavanone derivative |
| 03/11/2009 | CN101380463A Composition and its therapeutic use |
| 03/11/2009 | CN101380421A Leukoderma treating medicine |
| 03/11/2009 | CN101380417A Preparation for quickly treating urticaria |
| 03/11/2009 | CN101380410A Medicine for treating hyperactivity of fire due to yin deficiency and preparation method of the formulation thereof |
| 03/11/2009 | CN101380402A Ointment for treating burn and scald and preparation method thereof |
| 03/11/2009 | CN101380396A Pudendum powder and preparation method thereof |
| 03/11/2009 | CN101380380A Traditional Chinese medicine for treating seborrheic baldness and its preparation method |
| 03/11/2009 | CN101380373A Traditional Chinese medicine preparation for treating burn and scald |
| 03/11/2009 | CN101380370A Sanjing cosmetic paste and production method thereof |
| 03/11/2009 | CN101380357A Formulations for treating beriberi |
| 03/11/2009 | CN101380355A Medicine for treating beriberi and preparation method thereof |
| 03/11/2009 | CN101380349A Specific ointment for burn and scald |
| 03/11/2009 | CN101380338A Process of preparation of extracts rich in proanthocyanidins |
| 03/11/2009 | CN101380333A Method for extracting cellular fluid from human homogeneous variant cell |
| 03/11/2009 | CN101380321A Compounds, formulations, and methods for ameliorating telangiectasias |
| 03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 03/11/2009 | CN101380293A 10-acetyl-dithranol hydrogel and preparation method thereof |
| 03/11/2009 | CN101380288A Use of a Bifidobacterium species lysate for treating sensitive skin |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
| 03/11/2009 | CN100467449C Cyclic aminophenyl sulfamate derivative |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
| 03/11/2009 | CN100467066C Eye drip liquid which improves permeability by containing agar |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467058C Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 03/11/2009 | CN100467057C Nerve growth factor external application medicine and its preparing method |
| 03/11/2009 | CN100467048C External used Chinese traditional medicine preparation for treating verruca vulgaris and preparing method thereof |
| 03/11/2009 | CN100467019C Anti-inflammatory cream and production thereof |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501260 Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2289851C Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/05/2009 | WO2009028965A1 Surgical hydrogel |
| 03/05/2009 | WO2009028643A1 Method for production of carotenoid |
| 03/05/2009 | WO2009028495A1 Agent for fungal dermatitis |
| 03/05/2009 | WO2009028220A1 Collagen production promoter |
| 03/05/2009 | WO2009027823A2 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009027634A1 Antiseptics |
| 03/05/2009 | WO2009026816A1 The application of 1-aryl-2(1h)-pyridone compounds in preparation of medincines for treating itching of the skin |
| 03/05/2009 | WO2009026680A1 Supramacrqmolecular polymer complexes providing controlled nitric oxide release for healing wounds |
| 03/05/2009 | WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use |
| 03/05/2009 | WO2008156685A3 Tendon stem cells |
| 03/05/2009 | WO2008152334A3 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 03/05/2009 | WO2008149035A3 Novel active ingredient in cicatrization and use thereof |
| 03/05/2009 | WO2008145853A3 Use of an active ingredient derived from amaranth (amaranthus) for preparing a composition for activating cell energy and for protecting the skin against oxidative damage |
| 03/05/2009 | WO2008024893A3 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 03/05/2009 | WO2007126365A8 Further medical uses of antisecretory protein |
| 03/05/2009 | US20090062401 Decaline-derived compounds as pharmaceutically active agents |
| 03/05/2009 | US20090062390 In-shower lotion compositions comprising up to 10% free fatty acids wherein ratio of unsaturated to saturated fatty acids is at least 1:1 |
| 03/05/2009 | US20090062371 Oral preparation for promoting synthesis of tissue collagen |
| 03/05/2009 | US20090062370 Method for increasing the speed of recovery and/or the speed of wound healing of injured animals |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062247 METHODS FOR INHIBITING TGF-beta |
| 03/05/2009 | US20090062233 Modified starch material of biocompatible hemostasis |
| 03/05/2009 | US20090062224 Therapeutic use of cpg oligodeoxynucleotide for skin disease |
| 03/05/2009 | US20090062221 Azithromycin for treatment of skin disorders |
| 03/05/2009 | US20090062202 Methods of treating and preventing pressure ulcers with intradermal and transdermal delivery of calcitonin gene-related peptide (cgrp) |
| 03/05/2009 | US20090062187 Use of Hmgb1 for Wound Healing |
| 03/05/2009 | US20090062182 Deuterium-enriched dalbavancin |
| 03/05/2009 | US20090061020 Brimonidine Compositions for Treating Erythema |
| 03/05/2009 | US20090060985 Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
| 03/05/2009 | US20090060969 Porous biodegradable polymeric materials for cell transplantation |
| 03/05/2009 | US20090060962 Cosmetic use of bifidobacterium species lysate for the treatment of dryness |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060940 Compositions and methods for treating psoriasis by ganoderma lucidum (Reishi) polysaccharides |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |